Literature DB >> 21227717

Re-operations for aortic allograft root failure: experience from a 21-year single-center prospective follow-up study.

Jos A Bekkers1, Loes M A Klieverik, Goris Bol Raap, Johanna J M Takkenberg, Ad J J C Bogers.   

Abstract

OBJECTIVE: The study aims to report results of re-operations after aortic allograft root implantation.
METHODS: All consecutive patients in our prospective allograft database, who underwent aortic allograft root implantation, were selected for analysis, and additional information for patients who subsequently underwent re-operation was obtained from hospital records.
RESULTS: From 1989 to 2009, 262 aortic allograft root implantations were performed. Thirty-day mortality was 5.7%. During follow-up, 69 patients died. The actuarial survival was 77.0% (95% confidence interval (CI) 71-83%) after 10 years, and 65.1% (95% CI 57-74%) after 14 years. A total of 52 patients required re-operation. The actuarial freedom from allograft re-operation was 82.9% (Standard Error (SE) 2.9%) after 10 years and 55.7% (SE 5.7%) after 14 years. The actuarial median time to re-operation was 14.8 years. The indications for re-operation were structural valve dysfunction in 46 patients, endocarditis in two patients and non-structural valve dysfunction in four patients. The re-operations included 23 aortic valve replacements (mechanical prostheses 20 and bioprostheses 3), 27 aortic root replacements (mechanical conduits 21, aortic allografts five, and biological conduit one), one trans-apical valve implantation and one primary closure of a false aneurysm. The additional procedures were mitral valve repair (N = 5), mitral valve replacement (N = 1), ascending aortic replacement (N = 5), and coronary artery bypass grafting (CABG) (N = 4; in two patients unforeseen). Thirty-day mortality after re-operation occurred in two patients (3.9%). Five patients died during follow-up. The survival after re-operation was 87.1% (SE 5.5%) after 1 year and 79.3% (SE 7.4%) after 9 years.
CONCLUSIONS: Re-operations after aortic allograft root implantation will be required in a substantial and growing number of patients. These re-operations, although technically demanding, can be performed with satisfying results.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21227717     DOI: 10.1016/j.ejcts.2010.11.025

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Personalized screening intervals for biomarkers using joint models for longitudinal and survival data.

Authors:  Dimitris Rizopoulos; Jeremy M G Taylor; Joost Van Rosmalen; Ewout W Steyerberg; Johanna J M Takkenberg
Journal:  Biostatistics       Date:  2015-08-28       Impact factor: 5.899

Review 2.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

3.  Cardiovascular tissue banking in Europe.

Authors:  T M M H de By; R Parker; E M Delmo Walter; R Hetzer
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

Review 4.  A management framework for left sided endocarditis: a narrative review.

Authors:  Francesco Nappi; Cristiano Spadaccio; Marc R Moon
Journal:  Ann Transl Med       Date:  2020-12

Review 5.  Revisiting the guidelines and choice the ideal substitute for aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Cristiano Spadaccio; Christophe Acar
Journal:  Ann Transl Med       Date:  2020-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.